Results 21 to 30 of about 657,398 (291)

Confirmed severe acute respiratory syndrome coronavirus 2 encephalitis in cerebrospinal fluid: a case report

Journal of Medical Case Reports, 2022
Background Patients with severe acute respiratory syndrome coronavirus 2 infection show various clinical manifestations, including neurological .
Triana Ayuningtyas, Ronald Irwanto Natadidjaja, Chyntia Octaviani, Felly Sahli, Hadianti Adlani   +4 more
doaj   +1 more source

False-positive detection of IgM anti-severe acute respiratory syndrome coronavirus 2 antibodies in patients with rheumatoid arthritis: Possible effects of IgM or IgG rheumatoid factors on immunochromatographic assay results

SAGE Open Medicine, 2022
Objectives: The severe acute respiratory syndrome coronavirus 2 causes coronavirus disease 2019. A serological test is conducted to determine prior infection by severe acute respiratory syndrome coronavirus 2.
Shomi Oka, Takashi Higuchi, Hiroshi Furukawa, Kota Shimada, Atsushi Hashimoto, Toshihiro Matsui, Shigeto Tohma   +6 more
doaj   +1 more source

M-targeted anti-SARS-CoV-2 inhibitor-based drugs

Journal of Chemical Research, 2023
The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 is a global health emergency. The main protease is an important drug target in coronaviruses.
Zhuxin She, Yinuo Yao, Conglong Wang, Yi Li, Xiaohui Xiong, Yuanyuan Liu   +5 more
doaj   +1 more source

Detection and Profiling of Human Coronavirus Immunoglobulins in Critically Ill Coronavirus Disease 2019 Patients

Critical Care Explorations, 2021
Objectives:. Coronavirus disease 2019 continues to spread worldwide with high levels of morbidity and mortality. We performed anticoronavirus immunoglobulin G profiling of critically ill coronavirus disease 2019 patients to better define their underlying
Douglas D. Fraser, MD, PhD, Gediminas Cepinskas, DVM, PhD, Marat Slessarev, MD, MSc, Claudio M. Martin, MD, MSc, Mark Daley, PhD, Maitray A. Patel, BSc, Michael R. Miller, PhD, Eric K. Patterson, PhD, David B. O’Gorman, PhD, Sean E. Gill, PhD, Susanne Oehler, PhD, Markus Miholits, MSc, Brian Webb, PhD, on behalf of the Lawson COVID-19 Study Team, Robert Arntfield, Ian Ball, Gordon Barkwell, Tracey Bentall, Karen Bosma, Saoirse Cameron, Eileen Campbell, David Carter, Carolina Gillio-Meina, Robert Hegele, Natalya Odoardi, Ram Singh, Kelly Summers, Sue Tereschyn   +27 more
doaj   +1 more source

Features associated with SARS-COV-2 positivity among people presenting with acute respiratory tract infections to public Hospitals in Harari region, Ethiopia

SAGE Open Medicine, 2021
Background: Despite investigating coronavirus among respiratory tract infected cases is a top priority to prevent further transmission, severe acute respiratory syndrome coronavirus 2 positivity among this group of patients remains unexplored in resource-
Abdi Birhanu, Galana Mamo Ayana, Miesso Bayu, Ahmed Mohammed, Yadeta Dessie   +4 more
doaj   +1 more source

Review on development of potential inhibitors of SARS-CoV-2 main protease (MPro)

Future Journal of Pharmaceutical Sciences, 2022
Background The etiological agent for the coronavirus illness outbreak in 2019–2020 is a novel coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (COVID-19), whereas coronavirus disease pandemic of 2019 (COVID-19) has ...
Soumya Gulab Katre, Alpana Jagdish Asnani, Kumar Pratyush, Nilima Gangadhar Sakharkar, Ashwini Gajanan Bhope, Kanchan Tekram Sawarkar, Vaibhav Santosh Nimbekar   +6 more
doaj   +1 more source

Role of Eyes and Eyes Protection Amidst SARS-CoV-2 Infection

Journal of Nepal Medical Association, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 pandemic has infected millions of people. The conjunctival epithelium is easily exposed to infectious droplets and body fluids making eyes a potential route and reservoir of the infection.
Bibechan Thapa
doaj   +1 more source

Determining Cause of Death During Coronavirus Disease 2019 Pandemic

Critical Care Explorations, 2021
Objectives:. Controversy exists whether the cause of death due to severe acute respiratory syndrome coronavirus 2 is directly related to the infection or to underlying conditions.
Khaled M. Nada, MD, En-shuo Hsu, MS, Justin Seashore, MD, Mohammed Zaidan, MD, Shawn P. Nishi, MD, Alexander Duarte, MD, Gulshan Sharma, MD, MPH   +6 more
doaj   +1 more source

The Severe Acute Respiratory Syndrome

New England Journal of Medicine, 2003
The severe acute respiratory syndrome (SARS) is responsible for the first pandemic of the 21st century. Within months after its emergence in Guangdong Province in mainland China, it had affected more than 8000 patients and caused 774 deaths in 26 countries on five continents. It illustrated dramatically the potential of air travel and globalization for
Peiris, JSM, Osterhaus, ADME, Stöhr, K, Yuen, KY   +3 more
openaire   +4 more sources

Epigallocatechin gallate (EGCG) attenuates severe acute respiratory coronavirus disease 2 (SARS-CoV-2) infection by blocking the interaction of SARS-CoV-2 spike protein receptor-binding domain to human angiotensin-converting enzyme 2

PLoS ONE, 2022
The outbreak of the coronavirus disease 2019 caused by the severe acute respiratory syndrome coronavirus 2 triggered a global pandemic where control is needed through therapeutic and preventive interventions. This study aims to identify natural compounds
Tomokazu Ohishi, Takayuki Hishiki, Mirza S. Baig, Sajjan Rajpoot, Uzma Saqib, Tomohiko Takasaki, Yukihiko Hara   +6 more
doaj   +3 more sources